Chronic disease, type 2 diabetes, hypertension, chronic obstructive pulmonary disease, coronary heart disease Not Applicable
Conditions
Interventions
Current intervention as of 12/06/2023:
The intervention involves REaCH training for healthcare workers to deliver remote consulting via mobile phone to patients and will be compared to care as usual.
Tier 2 trainees are other cadres e.g. community health workers, pharmacy assistants, and medical assistants who may communicate in English or in local languages. The tier 1 and tier 2 trainees work as
Sponsors
King's College London
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Receiving healthcare from participating primary care facilities 2. Able to speak, read and write in English or local language 3. Give consent to participate in the study 4. Aged =18 years 5. Receiving treatment and/or monitoring for =1 of the following conditions: 5.1. Type 2 diabetes 5.2. Hypertension 5.3. Chronic obstructive pulmonary disease 5.4. Coronary heart disease 6. Contact with health facility =3 times per year
Exclusion criteria
Exclusion criteria: 1. No access to a mobile phone or fixed phone in the community 2. Identified by health workers as nearing the end of life or currently severely ill 3. Carers consulting on another person’s behalf 4. Unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Patient trust in healthcare provider measured using the Physician Humanistic Behaviour Questionnaire (PHBQ) at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 months 2. Face to face consultation rate defined as the number of visits per month for the eligible patient population where the patient is seen in person by the consulting health worker measured from the open cohort data at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 months 3. Remote consultation rate defined as the number of visits per month for the eligible patient population conducted using a telephone measured from the open cohort data at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 months 4. Prescribing rate defined as the number of prescriptions issued and collected to the eligible patient population per month. This outcome is a proxy for patient safety as a change in this outcome is an indicator of changes in safety and confidence measured from the open cohort data at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patient engagement with their health measured using the Patient Activation Measure (PAM-13) at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 months 2. Patient safety assessed from the number of investigations processed by the facility monthly, matched to the patient’s consultation type (where an increase may indicate a higher safety threshold when the person cannot be examined, and a decrease may indicate missed health needs) measured from the open cohort data at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 months | — |
Countries
Nigeria, Tanzania
Contacts
Public ContactRebecca Rogers
Outcome results
None listed